Global dynamics of antibiotic resistance: a modeling study of the spread of endemic and emerging resistance in E. coli
Year: 2025
Type: preprint
Abstract: Antibiotic resistance (ABR) is a global threat, yet its dynamics strongly vary across countries. Drivers of such heterogeneity remain unclear, limiting efforts to mitigate emergence and worldwide spread of multi-resistant clones. We developed a mechanistic modeling framework to analyze extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) dynamics globally accounting for antibiotic consumption and international mobility. Calibrated with data from 39 countries (2006-2019), the model is used to explore the global dissemination of potential emerging multi-resistant clones, like carbapenem-resistant E. coli (CR-EC). The model estimated heterogeneous within-country transmission rates and an excess risk of ABR acquisition under antibiotics of 9.83 (95%CrI:9.78-9.89). Simulations of potential CR-EC dissemination showed that mobility patterns drive early resistance dynamics, while long-term dynamics are mostly predicted by within-country transmission and antibiotic use. Our findings suggest that preventing introduction at the country-level is key to mitigate emerging threats but reducing within-country transmission and selection pressure is fundamental to avoid fixation.
Source: medRxiv
Institutions: Inserm, Institut Pasteur, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Centre de recherche en Epidémiologie et Santé des Populations, Sorbonne Université, Institut Pierre Louis d‘Épidémiologie et de Santé Publique, University of Oxford, Centre National de la Recherche Scientifique, Université Paris Cité, Génomique évolutive, modélisation et santé
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: green
Funder: Pfizer
Award: G5263545577
OpenAlex ID: W4414760655
